Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease leukemia
Phenotype C0879615|stromal tumor
Sentences 2
PubMedID- 24348666 It was initially proposed that the t790m mutation might prevent the proper binding of tyrosine kinase inhibitors via steric hindrance, similar to the corresponding gatekeeper mutations in bcr-abl (t315i) and kit (t670i) that confer resistance to imatinib (gleevec) in chronic myelogenous leukemia and in patients with gastrointestinal stromal tumors.
PubMedID- 21120166 Synchronous development of kit positive acute myeloid leukemia in a patient with gastrointestinal stromal tumor.

Page: 1